INSIGHTS ON QUALITY CONTROL

• Data Integrity In The Quality Control Lab: No Pen, No Pain

  Data integrity in pharmaceutical QC labs is critical for product safety. This webinar explores digital solutions to improve traceability, reduce paperwork, and enhance workflows.

• Leachables Method Development, Validation And Relevant ICH References

  It is crucial to develop and validate analytical methods capable of detecting a wide range of potential organic and inorganic leachables specific to the drug and its packaging.

• Enhancing Safety In Drug Substance Synthesis: A Smart Approach To Chemical Design

  Discover how safety‑by‑design principles in chemical synthesis help control exothermic reactions, reduce scale‑up risk, and enable safer, more reliable manufacturing of complex drug substances.

• Achieving Licensing For A Healthcare Solution

  Facing strict regulations and tricky powders, a healthcare client sought an advanced filling solution. Learn how an expert collaboration led to licensed product, boosting precision and productivity.

• Life Changing Products: Modernizing Regulated Product Development And Manufacturing

  7/6/2026

  Bridge the gap between your production floor and quality governance. Discover how a unified QMS and MES platform eliminates paper records, automates deviation triggers, and utilizes secure AI tools.

• Improving Bioprocess Monitoring And Control With Multivariate Data Analysis

  12/9/2024

  Learn about multivariate data analysis (MVDA) techniques, like PCA and PLS, that enable near real-time monitoring, prediction, and optimization of biomanufacturing processes.

• How A Global Biosimilars Company Cut Manual Data Errors By 50%

  5/8/2026

  Learn how a global biopharmaceutical leader halved transcription errors and integrated over 350 instruments to accelerate the development of high-quality, clinically proven biosimilars.

• Ask Us Anything: Hannah McLachlan on Crystallization In Peptide Development

  7/24/2026

  Hannah McLachlan, Project Scientist IV at Cambrex Edinburgh, on what crystallization screening delivers for peptide therapeutics — more stable material, higher purity, and a molecule clients can store without specialist infrastructure.

• Your Asset Data Determines Your Implementation Timeline

  3/10/2026

  Equipment records, not software configuration, most often delay maintenance system go-lives in regulated manufacturing. A structured 90-day approach to data readiness changes what teams should prioritize and when.